NCT07369505 2026-01-27Sapu003 in Advanced mTOR-sensitive Solid TumorsSAPU NANO (US) LLCPhase 1 Recruiting27 enrolled
NCT04803318 2024-06-25Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid TumorsSecond Affiliated Hospital of Guangzhou Medical UniversityPhase 2 Recruiting100 enrolled